Microsoft signs power purchase deal with nuclear fusion company Helion

By Timothy Gardner WASHINGTON (Reuters) -Private U.S. nuclear fusion company Helion Energy will provide Microsoft with electricity in about five years, the companies said on Wednesday, in the first such deal for the power source that fuels the sun but has been elusive on Earth. Government labs and more than 30 companies are racing to…

Read More

Ecuador seals record debt-for-nature swap with Galapagos bond

By Marc Jones and Rodrigo Campos LONDON/NEW YORK (Reuters) – Ecuador sealed the world’s largest “debt-for-nature” swap on record on Tuesday, selling a new “blue bond” that will funnel at least $12 million a year into conservation of the Galapagos Islands, one of the world’s most precious ecosystems. Having bought back roughly $1.6 billion of…

Read More

Metaverse could contribute up to 2.4% of US GDP by 2035 – study

(Reuters) – The metaverse could contribute as much as $760 billion or about 2.4% to U.S. annual gross domestic product (GDP) by 2035, according to a study commissioned by Facebook owner Meta Platforms. The concept of the metaverse includes augmented and virtual reality technologies that allow users to immerse themselves in a virtual world or…

Read More

Google AI pioneer says he quit to speak freely about technology’s ‘dangers’

(Reuters) – A pioneer of artificial intelligence said he quit Google to speak freely about the technology’s dangers, after realising computers could become smarter than people far sooner than he and other experts had expected. “I left so that I could talk about the dangers of AI without considering how this impacts Google,” Geoffrey Hinton…

Read More

After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic

By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several…

Read More

Lawmaker and head of NSF warn of delays to funding U.S. tech research

By Jane Lanhee Lee Santa Clara, California (Reuters) – Silicon Valley’s U.S. Democratic Representative Ro Khanna and the director of the National Science Foundation (NSF) warned on Friday against delays to funding for U.S. research in the face of surging technology investment by rivals such as China. While the CHIPS and Science Act authorized the…

Read More

CDC to scale back data collection as US ends COVID health emergency

By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) said on Friday it would stop reporting or monitoring COVID-19 case data and transmission rates after the government ends the pandemic’s public health emergency designation next week. The agency will stop using its color-coded COVID-19 Community Levels (CCL) system, which…

Read More

Drones over Kremlin likely launched from inside Russia – US experts

By Mike Stone WASHINGTON (Reuters) – The drones that crashed over the Kremlin earlier this week probably evaded an extensive number of defenses in and around Moscow, suggesting they might have been launched from inside Russia, U.S.-based drones experts said. Footage of the unmanned aircraft has sent governments and open source intelligence analysts on a…

Read More